First National Trust Co Has $439,000 Stock Position in Colgate-Palmolive (NYSE:CL)

First National Trust Co lifted its position in shares of Colgate-Palmolive (NYSE:CL) by 3.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,505 shares of the company’s stock after purchasing an additional 165 shares during the quarter. First National Trust Co’s holdings in Colgate-Palmolive were worth $439,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the company. &PARTNERS boosted its holdings in Colgate-Palmolive by 0.7% in the 4th quarter. &PARTNERS now owns 17,643 shares of the company’s stock worth $1,406,000 after buying an additional 129 shares during the last quarter. West Branch Capital LLC lifted its holdings in Colgate-Palmolive by 24.0% in the fourth quarter. West Branch Capital LLC now owns 682 shares of the company’s stock valued at $54,000 after acquiring an additional 132 shares during the last quarter. First Foundation Advisors grew its position in Colgate-Palmolive by 2.7% in the third quarter. First Foundation Advisors now owns 5,226 shares of the company’s stock worth $372,000 after acquiring an additional 136 shares during the period. Waldron Private Wealth LLC raised its position in Colgate-Palmolive by 2.7% in the third quarter. Waldron Private Wealth LLC now owns 5,361 shares of the company’s stock valued at $381,000 after purchasing an additional 140 shares during the period. Finally, Autumn Glory Partners LLC increased its position in shares of Colgate-Palmolive by 2.7% during the 4th quarter. Autumn Glory Partners LLC now owns 5,319 shares of the company’s stock worth $424,000 after purchasing an additional 140 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Colgate-Palmolive

In related news, insider Jennifer Daniels sold 3,538 shares of the stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $84.67, for a total value of $299,562.46. Following the completion of the sale, the insider now directly owns 59,698 shares in the company, valued at approximately $5,054,629.66. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other Colgate-Palmolive news, insider Jennifer Daniels sold 3,538 shares of the company’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $84.67, for a total transaction of $299,562.46. Following the sale, the insider now owns 59,698 shares in the company, valued at $5,054,629.66. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Noel R. Wallace sold 69,948 shares of the stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $84.22, for a total transaction of $5,891,020.56. Following the sale, the chief executive officer now directly owns 286,881 shares in the company, valued at $24,161,117.82. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 159,048 shares of company stock worth $13,336,846. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock traded down $0.03 during midday trading on Friday, hitting $92.88. 5,432,695 shares of the company’s stock were exchanged, compared to its average volume of 4,878,342. The company has a debt-to-equity ratio of 13.21, a quick ratio of 0.28 and a current ratio of 1.06. The stock has a market cap of $76.20 billion, a price-to-earnings ratio of 29.39, a price-to-earnings-growth ratio of 3.43 and a beta of 0.40. Colgate-Palmolive has a 12-month low of $67.62 and a 12-month high of $93.25. The firm’s 50 day simple moving average is $88.35 and its 200 day simple moving average is $82.21.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.82 by $0.04. The business had revenue of $5.07 billion during the quarter, compared to the consensus estimate of $4.96 billion. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The company’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.73 EPS. Equities research analysts predict that Colgate-Palmolive will post 3.52 EPS for the current year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be given a dividend of $0.50 per share. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, April 19th. This represents a $2.00 annualized dividend and a yield of 2.15%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.

Wall Street Analyst Weigh In

CL has been the topic of several research reports. Morgan Stanley increased their target price on Colgate-Palmolive from $85.00 to $93.00 and gave the stock an “overweight” rating in a research note on Monday, January 29th. The Goldman Sachs Group assumed coverage on shares of Colgate-Palmolive in a report on Friday, March 1st. They issued a “buy” rating and a $93.00 target price on the stock. UBS Group boosted their price target on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Monday, January 29th. Citigroup raised their price objective on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the company a “buy” rating in a report on Tuesday, April 16th. Finally, Stifel Nicolaus boosted their target price on shares of Colgate-Palmolive from $94.00 to $95.00 and gave the stock a “buy” rating in a research note on Monday, April 29th. Three analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat.com, Colgate-Palmolive presently has an average rating of “Moderate Buy” and an average price target of $91.44.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.